48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Schneider JA, Rosenbloom FM, Bradley KH, Seegmiller JE. Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochemical and Biophysical Research Communications. 29: 527-31. PMID 16496530 DOI: 10.1016/0006-291X(67)90516-5  0.335
1996 ENGELMAN K, WATTS RW, KLINENBERG JR, SJOERDSMA A, SEEGMILLER JE. CLINICAL, PHYSIOLOGICAL AND BIOCHEMICAL STUDIES OF A PATIENT WITH XANTHINURIA AND PHEOCHROMOCYTOMA. The American Journal of Medicine. 37: 839-61. PMID 14246087 DOI: 10.1016/0002-9343(64)90128-7  0.353
1991 Tarlé SA, Davidson BL, Wu VC, Zidar FJ, Seegmiller JE, Kelley WN, Palella TD. Determination of the mutations responsible for the Lesch-Nyhan syndrome in 17 subjects. Genomics. 10: 499-501. PMID 2071157 DOI: 10.1016/0888-7543(91)90341-B  0.574
1986 Gruber HE, Finley KD, Luchtman LA, Hershberg RM, Katzman SS, Laikind PK, Meyers EN, Seegmiller JE, Friedmann T, Yee JK. Insertion of hypoxanthine phosphoribosyltransferase cDNA into human bone marrow cells by a retrovirus. Advances in Experimental Medicine and Biology. 195: 171-5. PMID 3014831  0.395
1985 Gruber HE, Finley KD, Hershberg RM, Katzman SS, Laikind PK, Seegmiller JE, Friedmann T, Yee JK, Jolly DJ. Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. Science (New York, N.Y.). 230: 1057-61. PMID 3864246 DOI: 10.1126/Science.3864246  0.42
1985 Gruber HE, Friedmann T, Finley KD, Katzman S, Laikind PK, Hershberg RM, Luchtman LA, Seegmiller JE, Jolly DJ. INSERTION OF HYPOXAKTHINE PHOSPHORIBOSYLTRANSFERASE (HPRT) cDNA INTO HUMAN BONE MARROW CELLS (BMC) A RETROVIRUS VECTOR: 75 Pediatric Research. 19: 756-756. DOI: 10.1203/00006450-198507000-00095  0.394
1984 Willis RC, Jolly DJ, Miller AD, Plent MM, Esty AC, Anderson PJ, Chang HC, Jones OW, Seegmiller JE, Friedmann T. Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. The Journal of Biological Chemistry. 259: 7842-9. PMID 6203897  0.449
1980 Howell SB, Chu B, Mendelsohn J, Carson DA, Kung FH, Seegmiller JE. Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemia. Journal of the National Cancer Institute. 65: 277-84. PMID 6967527 DOI: 10.1093/Jnci/65.2.277  0.413
1979 Carson DA, Kaye J, Matsumoto S, Seegmiller JE, Thompson L. Uniqueness of deoxyribonucleotide metabolism in human malignant T cell lines. Advances in Experimental Medicine and Biology. 122: 381-8. PMID 317570  0.412
1979 Carson DA, Kaye J, Seegmiller JE. Metabolism and toxicity of 9-beta-D-arabinofuranosyladenine in human malignant T cells and B cells in tissue culture. Advances in Experimental Medicine and Biology. 122: 299-307. PMID 317567  0.4
1979 Carson DA, Kaye J, Matsumoto S, Seegmiller JE, Thompson L. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proceedings of the National Academy of Sciences of the United States of America. 76: 2430-3. PMID 313056 DOI: 10.1073/pnas.76.5.2430  0.411
1978 Carson DA, Kaye J, Seegmiller JE. Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine. Journal of Immunology (Baltimore, Md. : 1950). 121: 1726-31. PMID 309480  0.386
1978 Willis RC, Carson DA, Seegmiller JE. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proceedings of the National Academy of Sciences of the United States of America. 75: 3042-4. PMID 210448  0.41
1977 Watts RW, Kelley WN, Rapado A, Scott JT, Seegmiller JE, de Vries A, Wyngaarden JB, Zöllner N. Panel discussion: hyperuricemia as a risk factor. Advances in Experimental Medicine and Biology. 76: 342-64. PMID 855760 DOI: 10.1007/978-1-4684-3285-5_51  0.418
1977 Carson DA, Goldblum R, Keightley R, Seegmiller JE. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease. Advances in Experimental Medicine and Biology. 76: 463-70. PMID 855722 DOI: 10.1007/978-1-4613-4223-6_58  0.444
1977 Carson DA, Goldblum R, Seegmiller JE. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease. Journal of Immunology (Baltimore, Md. : 1950). 118: 270-3. PMID 830750  0.443
1977 Carson DA, Kaye J, Seegmiller JE. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proceedings of the National Academy of Sciences of the United States of America. 74: 5677-81. PMID 202960 DOI: 10.1073/Pnas.74.12.5677  0.428
1976 Carson DA, Seegmiller JE. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. The Journal of Clinical Investigation. 57: 274-82. PMID 176177 DOI: 10.1172/JCI108278  0.42
1972 Schulman JD, Schneider JA, Bradley KH, Seegmiller JE. Cystine, cysteine, and glutathione metabolism in normal and cystinotic fibroblasts in vitro, and in cultured normal amniotic fluid cells. Clinica Chimica Acta; International Journal of Clinical Chemistry. 35: 383-8. PMID 5166451 DOI: 10.1016/0009-8981(71)90210-5  0.332
1972 Seegmiller JE. New Prospects for Understanding and Control of Genetic Diseases Archives of Internal Medicine. 130: 181. DOI: 10.1001/Archinte.1972.03650020011003  0.32
1971 Schulman JD, Schneider JA, Bradley KH, Seegmiller JE. Heterozygote studies in cystinosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 29: 73-6. PMID 5500695 DOI: 10.1016/0009-8981(70)90223-8  0.329
1971 Seegmiller JE. Diseases of Uric Acid Metabolism. Annals of Internal Medicine. 74: 844. DOI: 10.7326/0003-4819-74-5-844_3  0.305
1970 Brubaker RF, Wong VG, Schulman JD, Seegmiller JE, Kuwabara T. Benign cystinosis. The clinical, biochemical and morphologic findings in a family with two affected siblings. The American Journal of Medicine. 49: 546-50. PMID 5477639 DOI: 10.1016/S0002-9343(70)80049-3  0.307
1970 Schulman JD, Lustberg TJ, Kennedy JL, Museles M, Seegmiller JE. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation. The American Journal of Medicine. 49: 118-24. PMID 5431474 DOI: 10.1016/S0002-9343(70)80121-8  0.352
1970 Greene ML, Boyle JA, Seegmiller JE. Substrate stabilization: genetically controlled reciprocal relationship of two human enzymes. Science (New York, N.Y.). 167: 887-9. PMID 5410854 DOI: 10.1126/Science.167.3919.887  0.308
1970 Kelley WN, Greene ML, Fox IH, Rosenbloom FM, Levy RI, Seegmiller JE. Effects of orotic acid on purine and lipoprotein metabolism in man. Metabolism: Clinical and Experimental. 19: 1025-35. PMID 4321643 DOI: 10.1016/0026-0495(70)90026-0  0.539
1969 Friedmann T, Seegmiller JE, Subak-Sharpe JH. Evidence against the existence of guanosine and inosine kinases in human fibroblasts in tissue culture. Experimental Cell Research. 56: 425-9. PMID 5824460 DOI: 10.1016/0014-4827(69)90034-2  0.416
1969 Henderson JF, Kelley WN, Rosenbloom FM, Seegmiller JE. Inheritance of purine phosphoribosyltransferases in man. American Journal of Human Genetics. 21: 61-70. PMID 5763607  0.462
1969 Kelley WN, Greene ML, Rosenbloom FM, Henderson JF, Seegmiller JE. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Annals of Internal Medicine. 70: 155-206. PMID 4884382 DOI: 10.7326/0003-4819-70-1-155  0.487
1968 Kaufman JM, Greene ML, Seegmiller JE. Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. The Journal of Pediatrics. 73: 583-92. PMID 5678000 DOI: 10.1016/S0022-3476(68)80274-4  0.323
1968 Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE. Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. The Journal of Clinical Investigation. 47: 2281-9. PMID 5676523 DOI: 10.1172/Jci105913  0.532
1968 Henderson JF, Miller HR, Kelley WN, Rosenbloom FM, Seegmiller JE. Kinetic studies of mutant human erythrocyte adenine phosphoribosyltransferases. Canadian Journal of Biochemistry. 46: 703-6. PMID 5665447 DOI: 10.1139/O68-108  0.543
1968 Henderson JF, Rosenbloom FM, Kelley WN, Seegmiller JE. Variations in purine metabolism of cultured skin fibroblasts from patients with gout. The Journal of Clinical Investigation. 47: 1511-6. PMID 5658584 DOI: 10.1172/Jci105844  0.56
1968 Henderson JF, Brox LW, Kelley WN, Rosenbloom FM, Seegmiller JE. Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase. The Journal of Biological Chemistry. 243: 2514-22. PMID 5651638  0.426
1968 Rosenbloom FM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE. Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. The Journal of Biological Chemistry. 243: 1166-73. PMID 5650894  0.474
1968 Seegmiller JE, Friedmann T, Harrison HE, Wong V, Schneider JA. Cystinosis. Combined clinical staff conference at the National Institutes of Health. Annals of Internal Medicine. 68: 883-905. PMID 5642970  0.345
1968 Kelley WN, Rosenbloom FM, Miller J, Seegmiller JE. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency. The New England Journal of Medicine. 278: 287-93. PMID 5638346 DOI: 10.1056/NEJM196802082780601  0.437
1968 Kelley WN, Rosenbloom FM, Seegmiller JE, Howell RR. Excessive production of uric acid in type I glycogen storage disease. The Journal of Pediatrics. 72: 488-96. PMID 5239290 DOI: 10.1016/S0022-3476(68)80339-7  0.488
1968 Seegmiller JE. Detection of Human Inborn Errors of Metabolism by Examination of Urinary Metabolites Clinical Chemistry. 14: 412-417. DOI: 10.1093/Clinchem/14.5.412  0.362
1968 FRIEDMANN T, SEEGMILLER JE, SUBAK-SHARPE JH. Metabolic Cooperation between Genetically Marked Human Fibroblasts in Tissue Culture Nature. 220: 272-274. DOI: 10.1038/220272A0  0.566
1967 Kelley WN, Rosenbloom FM, Seegmiller JE. The effects of azathioprine (imuran) on purine synthesis in clinical disorders of purine metabolism. The Journal of Clinical Investigation. 46: 1518-29. PMID 16695929 DOI: 10.1172/Jci105643  0.556
1967 Rosenbloom FM, Kelley WN, Miller J, Henderson JF, Seegmiller JE. Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. Jama. 202: 175-7. PMID 6072350 DOI: 10.1001/Jama.1967.03130160049007  0.559
1967 Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE. Xanthine phosphoribosyltransferase in man: relationship to hypoxanthine-guanine phosphoribosyltransferase. Biochemical and Biophysical Research Communications. 28: 340-5. PMID 6055161 DOI: 10.1016/0006-291X(67)90315-4  0.473
1967 Seegmiller JE, Rosenbloom FM, Kelley WN. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science (New York, N.Y.). 155: 1682-4. PMID 6020292 DOI: 10.1126/Science.155.3770.1682  0.567
1967 Alepa FP, Howell RR, Klinenberg JR, Seegmiller JE. Relationships between glycogen storage disease and tophaceous gout. The American Journal of Medicine. 42: 58-66. PMID 5225563 DOI: 10.1016/0002-9343(67)90006-X  0.336
1967 Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE. A specific enzyme defect in gout associated with overproduction of uric acid. Proceedings of the National Academy of Sciences of the United States of America. 57: 1735-9. PMID 4291947 DOI: 10.1073/Pnas.57.6.1735  0.496
1967 Rosenbloom F, Kelley W, Henderson J, Seegmiller J. LYON HYPOTHESIS AND X-LINKED DISEASE The Lancet. 290: 305-306. DOI: 10.1016/S0140-6736(67)90137-7  0.482
1964 Watts RWE, Engelman K, Klinenberg JR, Seegmiller JE, Sjoerdsma A. Enzyme Defect in a Case of Xanthinuria Nature. 201: 395-396. PMID 14110004 DOI: 10.1038/201395A0  0.349
Show low-probability matches.